USPTO serial 85362114
LG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 11, 2013
- Examiner
- AIKENS, RONALD E
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with LG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Seoul 150-721, KR
Seoul 150-721, KR
Seoul, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith Birch Stewart Kolasch & Birch, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations for the treatment of malignant tumor; Diagnostic reagents for pharmaceutical purpose; Diagnostic preparations for medicinal use; Drugs for medical purposes; Chemical preparations for medical purpose; Antibiotics for medical use; Adjuvants for medical use; Pharmaceutical preparations of multiple vitamins; Baby meals except for powdered milk; Dental filling material; Antiseptics; Germicides; Herbicides for home, garden and lawn use and for professional use; First-aid kits; Diagnostic reagents for medical use; Reagents for gene diagnosis; Culture media for medical purposes, namely, for cultivating human, animal, plant or microorganism cell; Pharmaceutical preparations for preserving human tissues; Veterinary preparations for preserving animal tissues; Pharmaceutical preparations for preserving internal organs of human; Veterinary preparations for preserving internal organs of animal; Diagnostic reagents for allergy; Veterinary preparations; Injectable dermal filler for recovering human skin; Pharmaceutical preparations for injection for use in smoothing out wrinkles and fine lines; Pharmaceutical preparations for injection for use in contouring the face; Diagnostic reagents for measuring hepatitis B surface antibody; Diagnostic reagents for measuring hepatitis C surface antibody; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment of endocrine disease; Pharmaceutical preparations for the treatment of musculoskeletal disease; Pharmaceutical preparations for the treatment of neurological disorder; Pharmaceutical preparations for the treatment of metabolic disease; Pharmaceutical preparations for the treatment of infectious disease; Pharmaceutical preparations for the treatment of autoimmune disease; Pharmaceutical preparations for the treatment of dermatosis; Vaccines; Pharmaceutical preparations of minerals; Adjunct preparations for the treatment of cancer. Pharmaceutical preparations for the treatment of anemia; Pharmaceutical preparations for the treatment of infertility; Pharmaceutical preparation for the purpose of inducing ovulation; Pharmaceutical preparations for the treatment of sexual disorder; Medical preparations for the purpose of contrast media; Adjunct preparations for surgical procedures on the eyes; Growth hormones for humans; Pharmaceutical preparations for the treatment of urologic disease; Analgesics; Drugs for fever reducing; Antiphlogistics ] | SECTION 8 - CANCELLED | — |
| 009 | [ DNA chips; Dosage dispensers, namely, machines for dispensing pre-determined dosages of medication; Capillary tubes for blood; Oxygen transvasing apparatus; Incubators for bacteria culture; Test tubes; Food analysis apparatus; Physical and chemical laboratory apparatus and instruments, namely, laboratory chemical reactors, beakers, gas mixers for laboratory use; Apparatus and instruments for physics, namely, wavemeters; Magnetic agitators; Pipettes; Chemistry apparatus and instruments, namely, flasks, gas mixers, laboratory chemical reactors; Computer software for managing medical data for medical purposes; Biochips; Cell chips; Analysis apparatus for cell chips, namely, chip card readers, optical readers; Diagnostic chips for medical purposes, namely, biochips; Computer software for use in diagnosing diseases for medical purposes; Computer database software for electronic chart for medical purposes; Amplifiers for polymerase chain reaction (PCR) used to amplify DNA for laboratory use; Rotating Stirrer; Laboratory apparatus for use in DNA extraction; Centrifugal separators; Kits comprised of laboratory apparatus, fittings, reagents and control solution; DNA extracting kits for laboratory apparatus; Low-temperature reactors for laboratory use; Enzyme reactors for laboratory use; Agitators; Absorption spectrophotometers; Double boilers for laboratory use; Protein chips ] | SECTION 8 - CANCELLED | — |
| 010 | Medical diagnostic imaging apparatus for displaying diagnostic images; [ Blood testing apparatus; Apparatus for blood analysis; Devices for measuring blood sugar; Diagnostic biochip apparatus for medical purposes, Radiological apparatus for medical purposes; Radiotherapy apparatus; Roentgen apparatus for medical purposes; ] X-ray appliances for dental; [ Irrigators for medical use; Heart pacemakers; Electric dental apparatus; Orthodontic machines and instruments for dental purposes; Nursing appliances; Suture materials for medical purposes; Electric blankets for medical purposes; Electric heating pads for medical purposes; Gloves for medical purposes; Masks for medical purposes; Lavage apparatus; Sterilizing apparatus for hospital use, namely, sterilization units for medical purposes; Portable X-ray appliances; ] Portable X-ray detectors; [ DNA analysis apparatus for medical purposes; DNA diagnostic biochips apparatus for medical purposes; DNA diagnostic apparatus for in vitro diagnosis; Automated External Defibrillator; Diagnosis apparatus for hereditary disease; Diagnosis apparatus for pregnancy testing; Diagnosis apparatus for hepatitis C virus; Diagnosis apparatus for Acquired Immune Deficiency Syndrome (AIDS); Diagnosis test apparatus for medical purposes; Diagnosis apparatus for testing virus infections; Diagnosis apparatus for testing microbial infections; Diagnosis apparatus for testing contagious infectious diseases; Detection test apparatus for pathogenic microbes; Diagnosis apparatus for determining allergies; Light irradiator for medical purposes; LED lamps for medical purposes; ] Electric massage apparatus for home and personal use; [ Lamps for medical purposes; Laser for medical purposes; ] Massage apparatus for medical purposes | ACTIVE | — |
| 035 | [ Commercial intermediary services, namely, mediation of contracts for the purchase and sale of products, services related to the purchase and sale of products, selling and purchasing in the field of medical machines and apparatus; Wholesale distributorships featuring pharmaceutical products; Retail store services featuring pharmaceutical products; Commercial intermediary services in the field of pharmaceutical products; Sales arranging of pharmaceutical products; Sales arranging of medical products ] | SECTION 8 - CANCELLED | — |
| 036 | [ Medical insurance services, namely, insurance claims adjustment; Health insurance underwriting; Insurance services, namely, insurance underwriting, insurance brokerage services; Insurance advisory services; Insurance information; Brokerage services of pharmaceutical products ] | SECTION 8 - CANCELLED | — |
| 037 | [ Construction of medical establishments; Building of hospitals; Repair of medical machines and apparatus ] | SECTION 8 - CANCELLED | — |
| 042 | [ Research and development of vaccines and medicines; Crude medicines research; Research on adult diseases; Bacteriological research; Research on cancer; Pharmaceutical development; Pharmaceutical research; Pharmaceutical advice; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Gene analysis; Genetic research; Research and development of DNA chips; Services for the planning of hospitals; Chemical research; Computer software development; Medical apparatus research; Research and development of diagnostic apparatus ] | SECTION 8 - CANCELLED | — |
| 044 | [ Medical nursing; Health care; Physical examination services; Hospitals; Medical clinics; Veterinary; Pharmacy; Pharmaceutical advice; Arranging of pharmaceutical preparations; Dispensing of pharmaceuticals; Pharmacy advice; Sanatoriums; Telemedicine services; Telemedicine; Medical nursing; Rental of medical machines and apparatus; Rental of medical and health care equipment; Medical assistance; Medical consultations; Medical clinics; Rental of X-ray apparatus for medical purposes; Providing health information; Medical product testing; Technology services on selecting medicines; Medical product information; Doctor'smedical practitioner's office; Clinical medicine; Midwife services; Performing diagnosis of diseases; Dental assistant services; Dentistry; Orthodontic services; Acupuncture; Health care by oriental medicines; Physical therapy by oriental medicines; Medical services by oriental medicines; Herb clinics; Oriental medical clinics; Blood testing; Blood bank services; Hospices; Convalescent homes ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LG Corp.
- Other trademarks owned by LG Corp.
- Other trademarks owned by LG Corp.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 037
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 21, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Oct 21, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 21, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 21, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 5, 2023 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Dec 5, 2023 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Dec 5, 2023 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Dec 5, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 9, 2023 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jun 11, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jul 20, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 20, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 20, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 20, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 24, 2019 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 24, 2019 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 24, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 11, 2019 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 2, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 11, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 11, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 26, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 15, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 14, 2013 | ALIE | ASSIGNED TO LIE | — |
| Feb 4, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 2, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2012 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 9, 2012 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 26, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 21, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 11, 2012 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 20, 2012 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 20, 2012 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 20, 2012 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 20, 2012 | ZZAX | PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU | — |
| Apr 16, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 12, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2012 | ALIE | ASSIGNED TO LIE | — |
| Mar 26, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2011 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Jul 11, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2011 | NWAP | NEW APPLICATION ENTERED | — |